The first domestic Viagra went on the market.

However, with the end of the "patent protection period" of Viagra in Pfizer in China 14, the domestic pharmaceutical industry's desire to share in the anti-ED drug market has been rekindled. Many pharmaceutical companies applied to produce imitation Viagra, but only Guangzhou Baiyunshan Pharmaceutical Company obtained the first wholesale license of imitation Viagra issued by the US Food and Drug Administration.

In the same year, Baiyunshan Pharmaceutical launched the generic drug Baiyunshan Jinge of American Viagra, which was the first domestic Viagra. As the main western medicine for treating ED, the global market is basically monopolized by Pfizer's Blue Viagra, Lilly's Yellow Xerox and Bayer's Orange Aleda. With the listing of 20 14 domestic Viagra, Baiyunshan Jinge broke the situation that foreign pharmaceutical companies monopolized the use of drugs for male sexual dysfunction in China with the advantage that the price of imported drugs was less than half.

According to the survey, in China, 46% of men over 40 suffer from erectile dysfunction, and most ED men are young and middle-aged, especially those who work in IT industry and offices. These men usually concentrate on mental work and lack enough physical exercise. In addition, people with diabetes, hypertension, dyslipidemia, smoking and obesity have a higher probability of ED than the general population.

The andrologist reminded that once impotence occurs, it is best to go to the hospital for medical treatment to avoid too much psychological burden for a long time. If patients don't want surgery, they can choose medication, and they can take Baiyunshan Jinge, an erectile dysfunction medication, preferably under the guidance of a doctor.